Canadian Journal of Anesthesia, Vol 39, 695-707, Copyright © 1992 by Canadian Anesthesiologists' Society

ARTICLES

Perioperative haemotherapy: I. Indications for blood component transfusion

ET Crosby
Department of Anaesthesia, Ottawa General Hospital, University of Ottawa, Ontario, Canada.

The practice of transfusion medicine has undergone substantial change over the last decade. Much of the impetus for the change has come from the isolation of human immunodeficiency virus (HIV) and the linkage of HIV transmission to blood transfusion. The purpose of this paper is to collate and review the literature relating to the indications for blood transfusion and provide recommendations for the appropriate utilization of blood products. Peer-reviewed and published studies and reviews relating to aspects of clinical blood transfusion were identified through computer searches and searching of the bibliographies of identified articles. Emphasis was placed on the literature published within the last decade and particularly in the years 1985-91. Material was chosen which was of proved clinical importance and in which findings were consistent among different investigators or different centres. Less emphasis was placed on material reporting new findings of uncertain clinical relevance or findings that were not consistent with majority reports. It is concluded that the only indication for red cell transfusion is to increase the oxygen carrying capacity of the blood and that an adjustment downwards in the haemoglobin concentration at which blood is transfused (transfusion trigger) from the traditional level of 100 g.L-1 is supported by the physiological and clinical data. Perioperative haemoglobin concentrations of 80 g.L-1 are acceptable in otherwise healthy young patients. The transfusion trigger should be adjusted upwards from this in medically compromised patients and in the elderly (greater than 60 yr). Fresh frozen plasma (FFP) is only indicated when there are documented deficiencies of coagulation factors. Platelet concentrates (PC) are indicated for the treatment of clinical coagulopathy resulting from thrombocytopaenia or platelet dysfunction. Routine or prophylactic administration of either FFP or PC after cardiopulmonary bypass or during resuscitation from haemorrhage is not indicated.

This article has been cited by other articles:

				P. C. Hebert, A. Tinmouth, and H. L. Corwin Controversies in RBC Transfusion in the Critically Ill Chest, May 1, 2007; 131(5): 1583 - 1590. [Abstract] [Full Text] [PDF]

				C. De Lorenzo, A. Calatzis, U. Welsch, and B. Heindl Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%. Anesth. Analg., April 1, 2006; 102(4): 1194 - 1200. [Abstract] [Full Text] [PDF]

				G. Nicol, E. Hunt, and M. Manji When to give blood Trauma, October 1, 2001; 3(4): 221 - 233. [Abstract] [PDF]

				E. A. M. van Rijen, J. J. Ward, and R. A. Little Effects of Colloidal Resuscitation Fluids on Reticuloendothelial Function and Resistance to Infection after Hemorrhage Clin. Vaccine Immunol., July 1, 1998; 5(4): 543 - 549. [Abstract] [Full Text]

				E. C. J. Consten, Ch. P. Henny, L. Eijsman, D. A. Dongelmans, and M. H. J. van Oers THE ROUTINE USE OF FRESH FROZEN PLASMA IN OPERATIONS WITH CARDIOPULMONARY BYPASS IS NOT JUSTIFIED J. Thorac. Cardiovasc. Surg., July 1, 1996; 112(1): 162 - 167. [Abstract] [Full Text]